IL17A and chronic obstructive pulmonary disease: Indeed, COPD patients have a greater number of IL-17- and IL-22-expressing cells in bronchial biopsies (83) and a recent study identified the presence of both natural cytotoxicity receptor (NCR)+ and NCR− ILC3 subsets in the lungs of COPD patients (14).